Human surrogate models of neuropathic pain: validity and limitations

被引：10
|
作者：
Binder, Andreas [1 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, Campus Kiel,Arnold Heller Str 3,Haus 41, D-24105 Kiel, Germany
来源：
PAIN | 2016年 / 157卷 / 02期
关键词：
Capsaicin; Menthol; Human pain model; Neuropathic pain; TOPICAL CAPSAICIN INDUCE; SENSITIZATION; MENTHOL; MECHANISMS; COLD; REPRODUCIBILITY; HYPERALGESIA; NOCICEPTORS; PHENOTYPE; ANALGESIA;
D O I：
10.1097/j.pain.0000000000000460
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Human surrogate models of neuropathic pain in healthy subjects are used to study symptoms, signs, and the hypothesized underlying mechanisms. Although different models are available, different spontaneous and evoked symptoms and signs are inducible; 2 key questions need to be answered: are human surrogate models conceptually valid, ie, do they share the sensory phenotype of neuropathic pain states, and are they sufficiently reliable to allow consistent translational research?
引用
收藏
页码：S48 / S52
页数：5
相关论文
共 50 条
  • [1] Human surrogate models of neuropathic pain: validity and limitations (vol 157, pg S48, 2016)
    Binder, A.
    PAIN, 2016, 157 (07) : 1578 - 1578
  • [2] Human surrogate models of neuropathic pain
    Klein, T
    Magerl, W
    Rolke, R
    Treede, RD
    PAIN, 2005, 115 (03) : 227 - 233
  • [3] Human surrogate models of neuropathic pain (vol 115, pg 227, 2005)
    Klein, T
    Magerl, W
    Rolke, R
    Treede, RD
    PAIN, 2006, 120 (1-2) : 224 - 225
  • [4] Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models
    Vollert, Jan
    Magerl, Walter
    Baron, Ralf
    Binder, Andreas
    Enax-Krumova, Elena K.
    Geisslinger, Gerd
    Gierthmuehlen, Janne
    Henrich, Florian
    Huellemann, Philipp
    Klein, Thomas
    Loetsch, Joern
    Maier, Christoph
    Oertel, Bruno
    Schuh-Hofer, Sigrid
    Toelle, Thomas R.
    Treede, Rolf-Detlef
    PAIN, 2018, 159 (06) : 1090 - 1102
  • [5] Preclinical surrogate models of spontaneous pain: an opportunity for drug development in neuropathic pain
    Serra, J.
    3RD INTERNATIONAL CONGRESS ON NEUROPATHIC PAIN (NEUPSIG), 2010, : 67 - 71
  • [6] Murine models of human neuropathic pain
    Colleoni, Mariapia
    Sacerdote, Paola
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (10): : 924 - 933
  • [7] Predictive validity of pharmacologic interventions in animal models of neuropathic pain
    Honore, Per Hartvig
    Basnet, Anna
    Kristensen, Pernille
    Andersen, Lene Munkholm
    Neustrup, Signe
    Mollgaard, Pia
    Eljaja, Laila
    Bjerrum, Ole J.
    SCANDINAVIAN JOURNAL OF PAIN, 2011, 2 (04) : 178 - 184
  • [8] Chances and limitations of human pain models
    Schmelz, M.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2009, 50 : 215 - 222
  • [9] The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial
    Jensen, MP
    Friedman, M
    Bonzo, D
    Richards, P
    CLINICAL JOURNAL OF PAIN, 2006, 22 (01): : 97 - 103
  • [10] Cytokine regulation in animal models of neuropathic pain and in human diseases
    Ueceyler, Nurcan
    Sommer, Claudia
    NEUROSCIENCE LETTERS, 2008, 437 (03) : 194 - 198
12345